At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 585 enrolled
Drug / intervention
IDP-120 Gel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris
In Brief
A Phase 3 clinical trial evaluating IDP-120 Gel and IDP-120 Vehicle Gel for Acne Vulgaris. Completed, enrolled 585 participants across 20 sites in 2 countries.
Detailed Summary
study designed to assess the safety, tolerability, and efficacy of IDP-120 Gel and IDP-120 Vehicle Gel
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesCanada, United States
Collaborators--
Timeline
Phase 3CompletedFinished
20192020202120222023202420252026
First PostedSep 2018
Enrollment StartDec 2018
Primary CompletionMay 2020
TodayJul 2026
First PostedSep 10, 2018
Enrollment StartDec 10, 2018
Primary CompletionMay 7, 2020
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 7.8 years ago
Interventions
IDP-120 Geldrug
IDP-120 Gel, once-daily application
IDP-120 Vehicle Geldrug
IDP-120 Vehicle Gel, once-daily application